Robert A. Floyd
Fondateur chez Otologic Pharmaceutics, Inc.
Profil
Robert A.
Floyd is the founder of Otologic Pharmaceutics, Inc. He currently works as a Principal at Oklahoma Medical Research Foundation since 1974.
Previously, he worked at Purdue University from 1966 to 1969.
Dr. Floyd received his doctorate degree from Purdue University in 1969, his graduate degree from the University of California, Davis in 1969, and his undergraduate and graduate degrees from the University of Kentucky in 1965.
Postes actifs de Robert A. Floyd
| Sociétés | Poste | Début |
|---|---|---|
Oklahoma Medical Research Foundation
 Oklahoma Medical Research Foundation Investment Trusts/Mutual FundsMiscellaneous Oklahoma Medical Research Foundation provides investment advice. The company was founded in 1946 and is headquartered in Oklahoma City, OK. | Corporate Officer/Principal | 12/03/2012 |
Otologic Pharmaceutics, Inc.
 Otologic Pharmaceutics, Inc. Pharmaceuticals: MajorHealth Technology Otologic Pharmaceutics, Inc. develops treatment for acute hearing loss. Its product HPN1010 is an oral medication to treat acute hearing loss to reduce the development of permanent hearing disorders. The company was founded by Richard Kopke, Robert A. Floyd and Dave karlman and is headquartered in Oklahoma City, OK. | Fondateur | - |
Formation de Robert A. Floyd
| University of Kentucky | Graduate Degree |
| Purdue University | Doctorate Degree |
| University of California, Davis | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Oklahoma Medical Research Foundation
Oklahoma Medical Research Foundation Investment Trusts/Mutual FundsMiscellaneous Oklahoma Medical Research Foundation provides investment advice. The company was founded in 1946 and is headquartered in Oklahoma City, OK. | Miscellaneous |
Otologic Pharmaceutics, Inc.
Otologic Pharmaceutics, Inc. Pharmaceuticals: MajorHealth Technology Otologic Pharmaceutics, Inc. develops treatment for acute hearing loss. Its product HPN1010 is an oral medication to treat acute hearing loss to reduce the development of permanent hearing disorders. The company was founded by Richard Kopke, Robert A. Floyd and Dave karlman and is headquartered in Oklahoma City, OK. | Health Technology |
